Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Air Lease A | AL | Nov 21, 2024 | 49.80 | +3.92 |
Air Lease Pref A | AL-A | Nov 21, 2024 | 25.18 | 0.00 |
Air Products And Chemicals | APD | Nov 21, 2024 | 328.88 | +0.31 |
Air T | AIRTP | Nov 21, 2024 | 17.35 | +1.39 |
Air T | AIRT | Nov 21, 2024 | 18.32 | +5.96 |
Air Transport Services Group | ATSG | Nov 21, 2024 | 21.96 | -0.14 |
Airbnb A | ABNB | Nov 21, 2024 | 133.26 | -1.47 |
Airgain | AIRG | Nov 21, 2024 | 8.58 | +1.06 |
AirNet Technology ADR | ANTE | Nov 21, 2024 | 0.49 | +4.22 |
AirSculpt Technologies | AIRS | Nov 21, 2024 | 6.78 | +6.77 |
Airship AI A | AISP | Nov 21, 2024 | 2.44 | -4.69 |
AIX ADR | AIFU | Nov 21, 2024 | 1.25 | 0.00 |
Akamai Technologies | AKAM | Nov 21, 2024 | 91.08 | +3.55 |
Akanda | AKAN | Nov 21, 2024 | 1.34 | -2.19 |
Akari Therapeutics ADR | AKTX | Nov 21, 2024 | 1.24 | -15.65 |
Akebia Therapeutics | AKBA | Nov 21, 2024 | 1.82 | +1.68 |
Akero Therapeutics | AKRO | Nov 21, 2024 | 31.20 | +1.84 |
Akoustis Technologies | AKTS | Nov 21, 2024 | 0.10 | +19.86 |
Akoya BioSciences | AKYA | Nov 21, 2024 | 2.12 | -1.85 |
Akso Health ADR | AHG | Nov 21, 2024 | 0.88 | +0.06 |
Alamo Group | ALG | Nov 21, 2024 | 196.36 | +2.41 |
Alamos Gold | AGI | Nov 21, 2024 | 18.86 | +0.80 |
Alarm.com | ALRM | Nov 21, 2024 | 60.78 | +0.96 |
Alarum Technologies ADR | ALAR | Nov 21, 2024 | 13.29 | +6.15 |
Alaska Air Group | ALK | Nov 21, 2024 | 52.30 | -1.58 |
Alaunos Therapeutics | TCRT | Nov 21, 2024 | 2.32 | +8.92 |
Albany International | AIN | Nov 21, 2024 | 82.53 | -1.23 |
Albemarle | ALB | Nov 21, 2024 | 108.98 | -0.52 |
Albemarle ADR A Pref | ALB-A | Nov 21, 2024 | 49.11 | -0.65 |
Albertsons Companies A | ACI | Nov 21, 2024 | 19.06 | -0.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.